Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Amortizatization of Intangibles (2016 - 2025)

Historic Amortizatization of Intangibles for Cardiff Oncology (CRDF) over the last 11 years, with Q3 2025 value amounting to $252000.0.

  • Cardiff Oncology's Amortizatization of Intangibles rose 6050.96% to $252000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $848000.0, marking a year-over-year increase of 3147.29%. This contributed to the annual value of $598000.0 for FY2024, which is 3507.06% down from last year.
  • Cardiff Oncology's Amortizatization of Intangibles amounted to $252000.0 in Q3 2025, which was up 6050.96% from $301000.0 recorded in Q2 2025.
  • Cardiff Oncology's 5-year Amortizatization of Intangibles high stood at $311000.0 for Q3 2023, and its period low was -$494000.0 during Q2 2021.
  • Over the past 5 years, Cardiff Oncology's median Amortizatization of Intangibles value was $137000.0 (recorded in 2025), while the average stood at -$1578.9.
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first tumbled by 6960.78% in 2022, then surged by 41250.0% in 2023.
  • Quarter analysis of 5 years shows Cardiff Oncology's Amortizatization of Intangibles stood at -$447000.0 in 2021, then surged by 108.95% to $40000.0 in 2022, then surged by 412.5% to $205000.0 in 2023, then dropped by 22.93% to $158000.0 in 2024, then soared by 59.49% to $252000.0 in 2025.
  • Its last three reported values are $252000.0 in Q3 2025, $301000.0 for Q2 2025, and $137000.0 during Q1 2025.